SGX Pharmaceuticals
Pharmaceutical company that developed structure-guided drug discovery approaches for oncology. Acquired by Eli Lilly in 2008 for approximately $64 million.
Location
San Diego, California, USA
Founded
2002
Investors
1
Categories
biotech, drug-discovery, oncology, acquired
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Apple Tree Partners | New York, USA | biotech-focused | series-aseries-b+2 | 23 |
